0 Évaluations
ID

31833

Description

Study ID: 105229 Clinical Study ID: GLP105229 Study Title: A double-blinded, randomized, placebo-controlled, staggered-parallel, escalating dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous injections of GSK 716155 in healthy volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Mots-clés

Versions (1)
  1. 01/10/2018 01/10/2018 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

1 octobre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Subcutaneous injections of GSK 716155 in healthy volunteers; Study ID: 105229

    Anglais

    Concomitant Medication

    1 Formulaires  
    1. StudyEvent: ODM
      1. Concomitant Medication
    Concomitant Medication
    Description

    Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852 (Concomitant Agent)
    Were any concomitant medications taken by the subject prior to screening and/or during the study?
    Description

    Concomitant Agent Before Screening procedure; Concomitant Agent During Clinical Trials

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0332152 (Before)
    SNOMED
    236874000
    UMLS CUI [1,3]
    C0220908 (Screening procedure)
    SNOMED
    20135006
    LOINC
    LP34059-3
    UMLS CUI [2,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [2,2]
    C0347984 (During)
    SNOMED
    371881003
    UMLS CUI [2,3]
    C0008976 (Clinical Trials)
    SNOMED
    110465008
    LOINC
    LP231796-6
    Drug Name
    Description

    Concomitant agent; medication name

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C2360065 (Medication name)
    LOINC
    MTHU027854
    Unit Dose
    Description

    Concomitant agent; dosage

    Type de données

    float

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0178602 (Dosage)
    SNOMED
    260911001
    LOINC
    LP7180-5
    Unit
    Description

    Concomitant agent; Unit

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0439148 (Unit)
    SNOMED
    767525000
    Frequency
    Description

    Concomitant agent; Frequency

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C3476109 (Medication frequency)
    LOINC
    LP149758-7
    Route
    Description

    Concomitant agent; Drug Administration Routes

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0013153 (Drug Administration Routes)
    SNOMED
    410675002
    LOINC
    LP40261-7
    Reason for Medication
    Description

    Concomitant agent; Indication

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C3146298 (Indication)
    Start Date
    Description

    Concomitant agent; Start Date

    Type de données

    date

    Alias
    UMLS CUI [1]
    C2826734 (Concomitant Medication Start Date)
    Start Time
    Description

    Concomitant agent; Start Time

    Type de données

    time

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C1301880 (Start time)
    SNOMED
    398201009
    LOINC
    LP102339-1
    Taken prior to study?
    Description

    Concomitant agent; before; clinical trial period

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0332152 (Before)
    SNOMED
    236874000
    UMLS CUI [1,3]
    C2347804 (Clinical Trial Period)
    Stop date
    Description

    Concomitant agent; Stop date

    Type de données

    date

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0806020 (End date)
    SNOMED
    454551000124105
    LOINC
    MTHU008302
    Stop time
    Description

    Concomitant agent; Stop time

    Type de données

    time

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C1522314 (End Time)
    SNOMED
    397898000
    Ongoing medication?
    Description

    Concomitant medication ongoing

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C2826666 (Concomitant Medication Ongoing)
    Retour au début de la page

    Similar models

    Concomitant Medication

    1 Formulaires
    1. StudyEvent: ODM
      1. Concomitant Medication
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    Concomitant Medication
    C2347852 (UMLS CUI-1)
    Concomitant Agent Before Screening procedure; Concomitant Agent During Clinical Trials
    Item
    Were any concomitant medications taken by the subject prior to screening and/or during the study?
    boolean
    C2347852 (UMLS CUI [1,1])
    C0332152 (UMLS CUI [1,2])
    C0220908 (UMLS CUI [1,3])
    C2347852 (UMLS CUI [2,1])
    C0347984 (UMLS CUI [2,2])
    C0008976 (UMLS CUI [2,3])
    Concomitant agent; medication name
    Item
    Drug Name
    text
    C2347852 (UMLS CUI [1,1])
    C2360065 (UMLS CUI [1,2])
    Concomitant agent; dosage
    Item
    Unit Dose
    float
    C2347852 (UMLS CUI [1,1])
    C0178602 (UMLS CUI [1,2])
    Concomitant agent; Unit
    Item
    Unit
    text
    C2347852 (UMLS CUI [1,1])
    C0439148 (UMLS CUI [1,2])
    Concomitant agent; Frequency
    Item
    Frequency
    text
    C2347852 (UMLS CUI [1,1])
    C3476109 (UMLS CUI [1,2])
    Concomitant agent; Drug Administration Routes
    Item
    Route
    text
    C2347852 (UMLS CUI [1,1])
    C0013153 (UMLS CUI [1,2])
    Concomitant agent; Indication
    Item
    Reason for Medication
    text
    C2347852 (UMLS CUI [1,1])
    C3146298 (UMLS CUI [1,2])
    Concomitant agent; Start Date
    Item
    Start Date
    date
    C2826734 (UMLS CUI [1])
    Concomitant agent; Start Time
    Item
    Start Time
    time
    C2347852 (UMLS CUI [1,1])
    C1301880 (UMLS CUI [1,2])
    Concomitant agent; before; clinical trial period
    Item
    Taken prior to study?
    boolean
    C2347852 (UMLS CUI [1,1])
    C0332152 (UMLS CUI [1,2])
    C2347804 (UMLS CUI [1,3])
    Concomitant agent; Stop date
    Item
    Stop date
    date
    C2347852 (UMLS CUI [1,1])
    C0806020 (UMLS CUI [1,2])
    Concomitant agent; Stop time
    Item
    Stop time
    time
    C2347852 (UMLS CUI [1,1])
    C1522314 (UMLS CUI [1,2])
    Concomitant medication ongoing
    Item
    Ongoing medication?
    boolean
    C2826666 (UMLS CUI [1])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial